Zhejiang East Asia Pharmaceutical Co., Ltd.

¥20.24As of Sun 8 Nov 2026, 12:00 UTC
SSE:605177Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (14.01%)
Div yield —
ROE (12.07%)
Biotechnology
Beta (5Y) 0.87
PE TTM —
TSR TTM (1.03%)
Mkt cap ¥2.278B
ROIC (6.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
20.19%
(29.96%)
Buy 8|3|9|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.27
0.29
0.29
3.24%
11.23%
18.66%
17.54%
Revenue¥M
202.9
200.7
204.6
216.9
9.49%
4.71%
1.37%
9.57%
Peers (US$341.5M)
Cap (US$)
PE
356.5M
14.33x
341.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.450
(0.031)
(0.031)
EBIT/Intx
2.258
0.376
0.355
Own earn%
174.81
224.86
175.19
Sh yield%
18.69
18.75
18.22
Owners
Insiders/Inst%
13.93
88.66
Short interest%
1.05
SBC / revenue%
4.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–22
$1 testx
0.0
Incr. ROIC%
4